Lycopene for the treatment for metabolic dysfunction
AssigneeCammedica Limited
InventorsIvan Petyaev, George Bash
Life of this patent
Estimating the term…
Abstract
This invention relates to the treatment of metabolic dysfunction and disorders associated with metabolic dysfunction using lycopene compounds. Methods of treatment and uses of lycopene compounds in such methods are provided.
Claims48
A method of treating metabolic dysfunction comprising;
- administering a lycopene compound in a therapeutically effective amount to an individual in need thereof.
12-22. (canceled)
A method of treating of a condition associated with metabolic dysfunction comprising:
- administering a lycopene compound in a therapeutically effective amount to an individual in need thereof.
34-44. (canceled)
A kit containing a lycopene compound and a statin for use in combination to treat metabolic dysfunction.
A kit containing a lycopene compound and a statin for use in combination to treat a condition associated with metabolic dysfunction.
59-76. (canceled)
A food product comprising a lycopene compound for treating metabolic dysfunction, wherein the lycopene compound is not naturally present in the food product.
A method of making a food product for treating metabolic dysfunction comprising
- (i) providing a food product ingredient,
- (ii) mixing a lycopene compound with said ingredient
- (iii) formulating said ingredient and said lycopene compound into a food product.
Dependencies are inferred from the claim text.